Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy

PHASE2CompletedINTERVENTIONAL

Enrollment

176

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions

Chronic Plaque Psoriasis

Interventions

DRUG

Certolizumab Pegol

"* Pharmaceutical Form: solution for injection in pre-filled syringe~* Route of Administration: subcutaneous use"

OTHER

Placebo

Matching Placebo to Certolizumab Pegol

Trial Locations (15)

Besançon

Créteil

Nice

Paris

Pierre-Bénite

Saint-Etienne

Berlin

Bonn

Essen

Frankfurt

Göttingen

Hamburg

Kiel

Mainz

Münster